Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -3.45 is 44% below its 5-year average of -2.39, around the middle of its 5-year range (-8.05–5.65).
As of the fiscal period ended Tuesday, June 30, 2026. 6.33% below its 12-month average of -3.25.
Reported quarterly debt to equity ratio; no daily interpolation. Q4 FY2026 (2026-06-30): -3.45.
DEBT TO EQUITY RATIO
-3.45
DEBT TO EQUITY RATIO AVG TTM
-3.25
DEBT TO EQUITY RATIO AVG 3Y
-2.37
DEBT TO EQUITY RATIO AVG 5Y
-2.39
DEBT TO EQUITY RATIO AVG 10Y
-0.07
DEBT TO EQUITY RATIO AVG 15Y
0.34
DEBT TO EQUITY RATIO AVG 20Y
0.70
CURRENT VS TTM AVG
-6.33%
CURRENT VS 3Y AVG
-45.70%
CURRENT VS 5Y AVG
-44.32%
CURRENT VS 10Y AVG
-4931.88%
CURRENT VS 15Y AVG
-1122.30%
CURRENT VS 20Y AVG
-592.91%
SECTOR MEDIAN · HEALTHCARE
0.69
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
-603.73%
vs the sector median at left
Cardinal Health, Inc.
Market Cap
$54.94B
Debt to Equity Ratio
-3.45
TTM Avg
-3.25
3Y Avg
-2.37
5Y Avg
-2.39
Market Cap
$49.00B
Debt to Equity Ratio
0.69
TTM Avg
0.79
3Y Avg
0.73
5Y Avg
0.74
Market Cap
$48.58B
Debt to Equity Ratio
0.07
TTM Avg
0.07
3Y Avg
0.09
5Y Avg
0.11
Market Cap
$63.88B
Debt to Equity Ratio
0.51
TTM Avg
0.51
3Y Avg
0.51
5Y Avg
0.54
Market Cap
$43.20B
Debt to Equity Ratio
2.18
TTM Avg
2.78
3Y Avg
2.75
5Y Avg
2.65
Market Cap
$43.09B
Debt to Equity Ratio
2.63
TTM Avg
2.41
3Y Avg
2.34
5Y Avg
2.26
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $54.94B | -3.45 | -3.25 | -2.37 | -2.39 |
| Moderna, Inc. (MRNA)vs › | $57.13B | 0.19 | 0.15 | 0.11 | 0.10 |
| Humana Inc. (HUM)vs › | $49.21B | 0.74 | 0.74 | 0.75 | 0.72 |
| Becton, Dickinson and Company (BDX)vs › | $49.00B | 0.69 | 0.79 | 0.73 | 0.74 |
| Edwards Lifesciences Corporation (EW)vs › | $48.58B | 0.07 | 0.07 | 0.09 | 0.11 |
| Cencora, Inc. (COR)vs › | $62.57B | 3.84 | 8.71 | 10.16 | 17.42 |
| Boston Scientific Corporation (BSX)vs › | $63.88B | 0.51 | 0.51 | 0.51 | 0.54 |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $43.20B | 2.18 | 2.78 | 2.75 | 2.65 |
| IQVIA Holdings Inc. (IQV)vs › | $43.09B | 2.63 | 2.41 | 2.34 | 2.26 |
| Agilent Technologies, Inc. (A)vs › | $41.50B | 0.54 | 0.55 | 0.53 | 0.52 |
Debt/Equity
-3.45
Current Ratio
0.88
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -3.45 |
| 2026-03-31 | -3.15 |
| 2025-12-31 | -3.13 |
| 2025-09-30 | -3.14 |
| 2025-06-30 | -3.36 |
| 2025-03-31 | -2.60 |
| 2024-12-31 | -2.54 |
| 2024-09-30 | -1.58 |
| 2024-06-30 | -1.75 |
| 2024-03-31 | -1.79 |
| 2023-12-31 | -1.37 |
| 2023-09-30 | -1.34 |
| 2023-06-30 | -1.59 |
| 2023-03-31 | -2.13 |
| 2022-12-31 | -2.38 |
| 2022-09-30 | -2.96 |
| 2022-06-30 | -7.50 |
| 2022-03-31 | -8.05 |
| 2021-12-31 | 5.65 |
| 2021-09-30 | 4.06 |
| 2021-06-30 | 3.48 |
| 2021-03-31 | 3.76 |
| 2020-12-31 | 3.42 |
| 2020-09-30 | 4.74 |
| 2020-06-30 | 3.79 |
| 2020-03-31 | 6.04 |
| 2019-12-31 | 7.94 |
| 2019-09-30 | 8.88 |
| 2019-06-30 | 1.27 |
| 2019-03-31 | 1.46 |
| 2018-12-31 | 1.50 |
| 2018-09-30 | 1.52 |
| 2018-06-30 | 1.49 |
| 2018-03-31 | 1.27 |
| 2017-12-31 | 1.28 |
| 2017-09-30 | 1.50 |
| 2017-06-30 | 1.53 |
| 2017-03-31 | 0.82 |
| 2016-12-31 | 0.86 |
| 2016-09-30 | 0.85 |
| 2016-06-30 | 0.85 |
| 2016-03-31 | 0.83 |
| 2015-12-31 | 0.82 |
| 2015-09-30 | 0.85 |
| 2015-06-30 | 0.88 |
| 2015-03-31 | 0.63 |
| 2014-12-31 | 0.65 |
| 2014-09-30 | 0.64 |
| 2014-06-30 | 0.62 |
| 2014-03-31 | 0.60 |
| 2013-12-31 | 0.60 |
| 2013-09-30 | 0.62 |
| 2013-06-30 | 0.65 |
| 2013-03-31 | 0.61 |
| 2012-12-31 | 0.44 |
| 2012-09-30 | 0.46 |
| 2012-06-30 | 0.46 |
| 2012-03-31 | 0.41 |
| 2011-12-31 | 0.43 |
| 2011-09-30 | 0.44 |
| 2011-06-30 | 0.43 |
| 2011-03-31 | 0.44 |
| 2010-12-31 | 0.49 |
| 2010-09-30 | 0.41 |
| 2010-06-30 | 0.40 |
| 2010-03-31 | 0.39 |
| 2009-12-31 | 0.40 |
| 2009-09-30 | 0.50 |
| 2009-06-30 | 0.42 |
| 2009-03-31 | 0.44 |
| 2008-12-31 | 0.47 |
| 2008-09-30 | 0.48 |
| 2008-06-30 | 0.50 |
| 2008-03-31 | 0.51 |
| 2007-12-31 | 0.57 |
| 2007-09-30 | 0.53 |
| 2007-06-30 | 0.47 |
| 2007-03-31 | 0.41 |
| 2006-12-31 | 0.34 |
| 2006-09-30 | 0.35 |
| 2006-06-30 | 0.33 |
| 2006-03-31 | 0.33 |
| 2005-12-31 | 0.34 |
| 2005-09-30 | 0.29 |
| 2005-06-30 | 0.31 |
| 2005-03-31 | 0.33 |
| 2004-12-31 | 0.33 |
| 2004-09-30 | 0.40 |
| 2004-06-30 | 0.46 |
| 2004-03-31 | 0.33 |
| 2003-12-31 | 0.36 |
| 2003-09-30 | 0.38 |
| 2003-06-30 | 0.35 |
| 2003-03-31 | 0.33 |
| 2002-12-31 | 0.35 |
| 2002-09-30 | 0.35 |